PDA Comments: SUPAC-IR, ICH Q1C, FDA Draft Guideline

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

You are going to email the following PDA Comments: SUPAC-IR, ICH Q1C, FDA Draft Guideline

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.